Life Edit will receive an upfront cash payment and is eligible to receive milestone payments of 250-335 million US dollars for each of seven development programmes, as well as tiered royalties on. | May 24, 2023
Capitalising on strong demand for its obesity therapies, Novo Nordisk's growing appetite for deals has fuelled a bet on a U.S. gene-editing company called Life Edit Therapeutics.
SoftBank-backed ElevateBio touts $401M funding round, Novo partnership mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.
How Did ElevateBio Manage To Nab $401M In This Economy? crunchbase.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crunchbase.com Daily Mail and Mail on Sunday newspapers.